Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Clarus
CLAR
$147M
| $490K | ﹤0.01% |
51,900
-5,000
| -9% | -$47.3K |
|
2527
Star Holdings Shares of Beneficial Interest
STHO
$118M
| $490K | ﹤0.01% |
+28,183
| New | +$490K |
|
2528
Ranpak Holdings
PACK
$395M
| $490K | ﹤0.01% |
93,800
-11,100
| -11% | -$57.9K |
|
2529
Traeger
COOK
$177M
| $490K | ﹤0.01% |
119,100
-6,100
| -5% | -$25.1K |
|
2530
ATAI Life Sciences
ATAI
$992M
| $486K | ﹤0.01% |
268,600
-24,400
| -8% | -$44.2K |
|
2531
fuboTV
FUBO
$1.46B
| $485K | ﹤0.01% |
400,500
-24,600
| -6% | -$29.8K |
|
|
TVRD
2532
Tvardi Therapeutics, Inc. Common Stock
TVRD
$318M
| $484K | ﹤0.01% |
2,739
-322
| -11% | -$56.9K |
|
2533
Bridgewater Bancshares
BWB
$457M
| $484K | ﹤0.01% |
44,638
-5,300
| -11% | -$57.5K |
|
2534
Distribution Solutions Group
DSGR
$1.44B
| $477K | ﹤0.01% |
+21,000
| New | +$477K |
|
2535
Five Star Bancorp
FSBC
$701M
| $476K | ﹤0.01% |
22,296
-2,700
| -11% | -$57.6K |
|
2536
Couchbase
BASE
$1.35B
| $475K | ﹤0.01% |
33,800
-2,700
| -7% | -$38K |
|
2537
ImmunityBio
IBRX
$2.46B
| $472K | ﹤0.01% |
259,200
-30,800
| -11% | -$56.1K |
|
2538
Rimini Street
RMNI
$417M
| $471K | ﹤0.01% |
114,400
-8,500
| -7% | -$35K |
|
2539
Hagerty
HGTY
$1.24B
| $471K | ﹤0.01% |
53,900
-4,300
| -7% | -$37.6K |
|
2540
Workhorse Group
WKHS
$17.7M
| $471K | ﹤0.01% |
1,417
-134
| -9% | -$44.5K |
|
2541
Tarsus Pharmaceuticals
TARS
$2.08B
| $471K | ﹤0.01% |
37,433
-4,400
| -11% | -$55.3K |
|
2542
Cambium Networks
CMBM
$20.4M
| $466K | ﹤0.01% |
26,300
-3,000
| -10% | -$53.2K |
|
2543
Gilat Satellite Networks
GILT
$619M
| $466K | ﹤0.01% |
92,328
-8,337
| -8% | -$42.1K |
|
2544
Butterfly Network
BFLY
$395M
| $459K | ﹤0.01% |
244,300
-27,400
| -10% | -$51.5K |
|
2545
KRONOS Worldwide
KRO
$694M
| $459K | ﹤0.01% |
49,800
-4,900
| -9% | -$45.1K |
|
2546
Kodiak Sciences
KOD
$489M
| $455K | ﹤0.01% |
73,400
-6,100
| -8% | -$37.8K |
|
|
ACB
2547
Aurora Cannabis
ACB
$274M
| $454K | ﹤0.01% |
65,427
-7,470
| -10% | -$51.9K |
|
2548
Altimmune
ALT
$321M
| $448K | ﹤0.01% |
106,100
-12,200
| -10% | -$51.5K |
|
2549
Erasca
ERAS
$443M
| $447K | ﹤0.01% |
148,600
-12,600
| -8% | -$37.9K |
|
2550
Hippo Holdings
HIPO
$933M
| $445K | ﹤0.01% |
27,408
-3,000
| -10% | -$48.7K |
|